DBXE 📈 Xtrackers - Euro Stoxx 50 - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0274211217 • Eurozone Large-Cap Equity
DBXE: Stocks, Bonds, European Equities
The Xtrackers - Euro Stoxx 50 UCITS ETF, listed on XETRA as DBXE, is a financial instrument that provides exposure to the Eurozone's large-cap equity market. Its underlying index, the Morningstar Dev Ezn TME NR EUR, serves as a benchmark to track the performance of a diversified portfolio of stocks from leading Eurozone companies. With its domicile in Luxembourg, this ETF is subject to the regulatory framework of the Grand Duchy, which is known for its favorable investment environment and strong financial sector. The ETF's ISIN, LU0274211217, is a unique identifier that facilitates its trading and settlement across various financial platforms.
As an exchange-traded fund (ETF), the Xtrackers - Euro Stoxx 50 UCITS ETF offers a range of benefits to investors, including transparency, liquidity, and cost-efficiency. Its listing on XETRA, a major European stock exchange, ensures that investors can easily buy and sell shares throughout the trading day. The fund's website, accessible through the company URL http://www.dws.lu, provides detailed information on its investment objectives, portfolio composition, and performance metrics. By tracking the Morningstar Dev Ezn TME NR EUR index, this ETF aims to replicate the returns of the Eurozone's large-cap equity market, making it an attractive option for investors seeking to diversify their portfolios and gain exposure to this specific asset class.
The Euro Stoxx 50 index, which serves as a proxy for the broader Eurozone equity market, is a widely recognized benchmark that comprises 50 of the largest and most liquid stocks in the Eurozone. The Xtrackers - Euro Stoxx 50 UCITS ETF, by tracking this index, provides investors with a convenient and efficient way to gain exposure to a diversified portfolio of leading Eurozone companies, including those from various sectors such as finance, industrials, and consumer goods. With its UCITS (Undertakings for the Collective Investment in Transferable Securities) compliance, this ETF is subject to a stringent regulatory framework that ensures investor protection and transparency, making it an attractive option for both institutional and retail investors seeking to invest in the Eurozone's large-cap equity market.
Additional Sources for DBXE ETF
DBXE ETF Overview
Market Cap in USD | 5,636m |
Category | Eurozone Large-Cap Equity |
TER | 0.09% |
IPO / Inception | 2007-01-04 |
DBXE ETF Ratings
Growth 5y | 46.5% |
Fundamental | - |
Dividend | 48.0% |
Rel. Strength Industry | 66.4 |
Analysts | - |
Fair Price Momentum | 49.20 EUR |
Fair Price DCF | - |
DBXE Dividends
Dividend Yield 12m | 3.16% |
Yield on Cost 5y | 4.40% |
Annual Growth 5y | 7.99% |
Payout Consistency | 79.1% |
DBXE Growth Ratios
Growth Correlation 3m | -35.2% |
Growth Correlation 12m | 4.4% |
Growth Correlation 5y | 88.3% |
CAGR 5y | 6.71% |
CAGR/Mean DD 5y | 0.93 |
Sharpe Ratio 12m | 0.29 |
Alpha | -12.66 |
Beta | 0.74 |
Volatility | 10.46% |
Current Volume | 155.1k |
Average Volume 20d | 96.4k |
As of December 22, 2024, the stock is trading at EUR 50.45 with a total of 155,148 shares traded.
Over the past week, the price has changed by -1.71%, over one month by +2.81%, over three months by -1.19% and over the past year by +7.30%.
Partly, yes. Based on ValueRay Analyses, Xtrackers - Euro Stoxx 50 (XETRA:DBXE) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 46.51 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXE as of December 2024 is 49.20. This means that DBXE is currently overvalued and has a potential downside of -2.48%.
Xtrackers - Euro Stoxx 50 has no consensus analysts rating.
According to ValueRays Forecast Model, DBXE Xtrackers - Euro Stoxx 50 will be worth about 54.3 in December 2025. The stock is currently trading at 50.45. This means that the stock has a potential upside of +7.57%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 54.3 | 7.6% |